D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$402M |
| 2 |
AGN
Allergan plc
AGN
|
+$371M |
| 3 |
Bank of America
BAC
|
+$323M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$236M |
Top Sells
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$364M |
| 4 |
Phillips 66
PSX
|
+$352M |
| 5 |
Apple
AAPL
|
+$350M |
Sector Composition
| 1 | Healthcare | 15.91% |
| 2 | Technology | 12.6% |
| 3 | Financials | 12.08% |
| 4 | Consumer Discretionary | 10.42% |
| 5 | Communication Services | 10.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARI
2176
Apollo Commercial Real Estate
ARI
$1.53B
| $337K | ﹤0.01% |
20,704
-66,367
| -76% | -$1.08M |
|
2177
Supernus Pharmaceuticals
SUPN
$2.62B
| $336K | ﹤0.01% |
22,010
-3,915
| -15% | -$59.8K |
|
|
OXFD
2178
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $336K | ﹤0.01% |
33,946
+1,423
| +4% | +$14.1K |
|
2179
Realty Income
O
$55B
| $334K | ﹤0.01% |
5,522
| – | – |
|
2180
Lithia Motors
LAD
$8.82B
| $332K | ﹤0.01% |
+3,800
| New | +$332K |
|
2181
Provident Financial Services
PFS
$2.61B
| $331K | ﹤0.01% |
+16,406
| New | +$331K |
|
2182
Winmark
WINA
$1.82B
| $331K | ﹤0.01% |
3,380
+4
| +0.1% | +$392 |
|
2183
Atlantic Union Bankshares
AUB
$5.04B
| $329K | ﹤0.01% |
+13,344
| New | +$329K |
|
|
GARS
2184
DELISTED
Garrison Capital Inc.
GARS
| $329K | ﹤0.01% |
30,640
+11,106
| +57% | +$119K |
|
2185
S&T Bancorp
STBA
$1.51B
| $328K | ﹤0.01% |
+12,744
| New | +$328K |
|
2186
Olympic Steel
ZEUS
$378M
| $327K | ﹤0.01% |
+18,878
| New | +$327K |
|
|
SUM
2187
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $326K | ﹤0.01% |
+17,507
| New | +$326K |
|
|
FBNK
2188
DELISTED
First Connecticut Bancorp, Inc
FBNK
| $325K | ﹤0.01% |
20,346
-3,247
| -14% | -$51.9K |
|
2189
Hancock Whitney
HWC
$5.38B
| $324K | ﹤0.01% |
+14,115
| New | +$324K |
|
2190
CoStar Group
CSGP
$36.9B
| $323K | ﹤0.01% |
+17,160
| New | +$323K |
|
2191
Scholastic
SCHL
$687M
| $323K | ﹤0.01% |
+8,654
| New | +$323K |
|
2192
Center Bancorp
CNOB
$1.27B
| $321K | ﹤0.01% |
19,642
-4,576
| -19% | -$74.8K |
|
2193
Forrester Research
FORR
$191M
| $321K | ﹤0.01% |
9,561
-5,440
| -36% | -$183K |
|
2194
Immunic
IMUX
$84.1M
| $321K | ﹤0.01% |
884
+416
| +89% | +$151K |
|
2195
Jones Lang LaSalle
JLL
$14.9B
| $318K | ﹤0.01% |
+2,712
| New | +$318K |
|
2196
UBS Group
UBS
$130B
| $318K | ﹤0.01% |
19,845
+1,300
| +7% | +$20.8K |
|
2197
Chegg
CHGG
$173M
| $317K | ﹤0.01% |
71,168
+47,093
| +196% | +$210K |
|
|
EPAY
2198
DELISTED
Bottomline Technologies Inc
EPAY
| $317K | ﹤0.01% |
10,399
-7,901
| -43% | -$241K |
|
|
ELGX
2199
DELISTED
Endologix Inc
ELGX
| $317K | ﹤0.01% |
3,790
-5,165
| -58% | -$432K |
|
|
SBNY
2200
DELISTED
Signature Bank
SBNY
| $317K | ﹤0.01% |
2,326
-76,043
| -97% | -$10.4M |
|